Clinical trials
Enrolling by invitation Tobacco Use Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ottawa Hospital Research Institute | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Medical University of South Carolina | 1 |
| Rochester Institute of Technology | 1 |
| Shanghai East Hospital | 1 |
| University of Liege | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tobacco Use Disorder | 8 |
| Substance-Related Disorders | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Mental Disorders | 1 |
| Periodontitis | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.